Agios pharmaceuticals, inc. (AGIO)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13
Operating activities
Net loss

-40,256

-102,350

-106,173

-109,871

-93,078

-91,794

-94,664

-68,745

-90,825

-88,285

-77,137

-83,082

-66,166

-56,486

-62,834

-55,953

-23,198

-40,622

-40,256

-31,897

-4,957

-26,664

3,704

-18,296

-12,248

-12,382

-11,177

-8,620

-7,228

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

2,474

1,963

2,082

2,037

2,005

1,911

1,797

1,739

1,725

1,654

1,614

1,573

1,591

1,714

1,436

1,304

1,246

1,145

1,047

780

370

362

346

327

332

340

377

374

349

Stock-based compensation expense

19,690

17,130

18,588

18,547

18,108

18,187

24,193

16,455

14,522

12,681

12,207

12,187

10,734

9,840

12,143

10,996

9,107

9,353

9,373

8,177

5,060

4,728

2,892

2,381

1,505

1,165

1,112

329

424

Net accretion of premium and discounts on investments

-126

423

753

888

1,131

1,297

1,249

885

406

36

69

69

-163

-239

-204

-204

-126

-108

-112

-147

-172

-126

-107

-137

-168

-203

-90

4

5

Loss on disposal of property and equipment

-

-

-

-

-

-

-

-

-

0

0

0

-40

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash operating lease expense

2,203

2,191

2,133

2,123

2,085

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Changes in operating assets and liabilities:
Accounts receivable, net

2,861

1,846

-41

2,792

-721

2,445

2,631

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Collaboration receivable – related party

1,038

-299

-686

205

-143

-933

-15,931

15,814

1,064

-1,041

-1,353

-6,423

6,379

-3,296

329

1,039

-1,411

-852

-1,397

3,458

524

-12,267

18,759

-2,619

2,143

-

-

-

-

Collaboration receivable – other

105

1,059

-1,353

582

970

230

0

440

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Royalty receivable – related party

400

300

-100

500

-34

371

290

156

195

507

715

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Inventory

2,447

1,482

1,190

2,331

1,459

6

863

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Tenant improvement and other receivables

-

-

-

-

-

-

-

-

-

-

-

-2,662

24

-

1,089

1,443

-2,803

381

-2,289

-1,625

4,573

-

-

-

-

-

-

-

-

Prepaid expenses and other current and non-current assets

6,774

4,190

1,035

344

2,173

563

702

-512

-1,901

1,714

-531

-1,008

3,425

-44

1,335

272

857

1,451

2,442

-833

708

122

1,965

-139

930

-

-

-

544

Accounts payable

-2,009

1,067

4,523

3,065

-4,939

342

368

-1,729

-4,469

4,587

-4,188

5,924

-994

1,833

-2,087

4,048

-293

5,539

-114

1,455

-2,665

5,223

670

964

720

1,208

-907

-1,100

829

Accrued expenses

-14,967

2,631

-2,469

12,168

-5,097

17,160

-696

9,303

-17,144

2,764

1,150

4,497

-6,889

9,526

8,161

2,069

-2,902

-836

5,027

-4,132

1,574

1,817

4,544

1,064

-2,194

2,398

635

1,544

301

Deferred revenue – related party

-56,765

-5,157

-3,400

-7,058

-15,391

-15,916

-5,105

-7,503

-3,141

-6,429

-8,957

-9,260

-1,924

-20,146

-4,653

196,537

-5,892

-4,525

-3,108

24,979

-31,393

-6,789

-15,141

8,970

-6,268

-6,268

-6,268

-6,268

-6,268

Operating lease liabilities

-2,229

-2,671

-541

-1,520

-2,129

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred rent

-

-

-

-

-

138

-72

112

-96

210

866

852

801

820

-1,353

-1,373

560

-256

-1,860

-5,471

-8,218

-3,611

-135

31

24

-

-

-51

15

Refundable income taxes and income taxes payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

3,841

0

0

655

-5,958

-3,684

116

90

176

Net cash used in operating activities

-105,358

-93,611

-85,589

-88,151

-103,271

-74,187

-63,839

-67,395

-99,000

-74,454

-77,715

-58,989

-74,074

-51,223

-49,030

157,824

-19,009

-30,529

-24,815

3,980

-25,585

-7,775

-23,467

-1,071

-27,040

-13,617

-14,980

-15,822

-11,981

Investing activities
Proceeds from maturities and sales of marketable securities

167,501

115,795

133,010

132,561

210,811

166,200

168,615

166,795

164,871

127,305

204,405

167,126

136,585

62,184

81,980

53,600

198,868

157,664

145,908

113,767

84,311

336,023

74,004

72,941

22,560

6,360

15,680

17,860

20,226

Investing activities
Purchases of marketable securities

54,911

293,744

50,591

66,810

77,421

177,952

162,704

261,693

330,971

84,177

135,969

441,816

26,740

138,480

141,298

15,126

211,163

134,520

112,452

70,679

35,526

621,836

89,045

91,526

34,812

26,551

96,303

7,280

15,915

Purchases of property and equipment

4,455

6,824

2,038

1,271

2,038

1,053

3,140

1,361

1,432

1,280

2,019

1,035

293

1,222

3,426

2,734

2,533

2,186

3,299

10,882

3,797

1,489

628

86

13

219

99

701

275

Net cash provided by investing activities

108,135

-184,773

80,381

64,480

131,352

-12,805

2,771

-96,259

-167,532

41,848

66,417

-275,725

109,552

-77,518

-62,744

35,740

-14,828

20,958

30,157

32,206

44,988

-287,302

-15,098

-18,671

-12,265

-20,410

-80,722

9,879

4,036

Financing activities
Proceeds from public offering of common stock, net of reimbursements

-

-

-

-

-

0

0

0

516,206

0

0

270,250

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments on financing lease obligations

80

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Reimbursement (payment) of public offering costs

-

-

-

-

-

0

0

203

188

549

193

-204

100

-

-

-

-

0

0

0

207

-

-

-

-

-

-

-

-

Net proceeds from stock option exercises and employee stock purchase plan

5,465

518

3,337

3,808

4,860

1,016

7,223

9,711

12,259

1,862

5,515

2,699

4,146

4,099

1,202

1,449

1,108

1,287

2,173

1,091

2,029

887

380

454

582

50

28

47

25

Net cash provided by financing activities

5,385

277,606

3,337

3,808

4,860

1,016

7,223

9,508

528,277

2,589

5,322

273,153

4,046

3,993

163,228

1,449

1,108

1,287

2,173

1,091

1,822

239,059

367

95,152

582

-424

124,232

47

25

Net change in cash and cash equivalents

8,162

-778

-1,871

-19,863

32,941

-85,976

-53,845

-154,146

261,745

-30,017

-5,976

-61,561

39,524

-124,748

51,454

195,013

-32,729

-8,284

7,515

37,277

21,225

-56,018

-38,198

75,410

-38,723

-34,451

28,530

-5,896

-7,920

Supplemental cash flow information
Cash paid for income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

22

0

0

5,958

-

-

-

-

Supplemental disclosure of non-cash investing and financing transactions
Vesting of restricted stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

12

-2

-6

2

16

-1

-9

3

-

-

-

16

Additions to property and equipment in accounts payable and accrued expenses

5,444

3,079

1,554

-192

727

605

-864

760

605

785

-1,157

1,170

213

-424

-863

753

607

1,083

-451

-5,071

6,602

1,921

185

-1

13

-

-

-

-

Proceeds from stock option exercises in other current assets

0

0

-112

-1,037

1,149

-32

39

-73

73

-95

92

-3

6

32

-23

6

17

-14

197

-57

60

-

-

-

-

-

-

-

-

Operating lease liabilities arising from obtaining operating lease assets

0

0

-534

42,856

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Financing lease liabilities arising from obtaining financing lease assets

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Public offering costs in other current assets, net of amounts in accounts payable and accrued expenses

-

-

-

-

-

-

-

-

158

-

193

-204

329

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Public offering costs in accounts payable and accrued expenses

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-52

65

-

-

-

-